Analysts Conflicted on These Healthcare Names: Nektar Therapeutics (NKTR), Resmed (RMD) and MiMedx Group (MDXG)

Analysts have been eager to weigh in on the Healthcare sector with new ratings on Nektar Therapeutics (NKTR – Research Report), Resmed (RMD – Research Report) and MiMedx Group (MDXG – Research Report).

Nektar Therapeutics (NKTR)

J.P. Morgan analyst Jessica Fye downgraded Nektar Therapeutics to Sell yesterday. The company’s shares closed last Tuesday at $3.76, close to its 52-week low of $3.02.

According to TipRanks.com, Fye is a 4-star analyst with an average return of 8.1% and a 52.3% success rate. Fye covers the Healthcare sector, focusing on stocks such as Cerevel Therapeutics Holdings, Crinetics Pharmaceuticals, and Intra-Cellular Therapies.

Nektar Therapeutics has an analyst consensus of Hold, with a price target consensus of $5.23.

See the top stocks recommended by analysts >>

Resmed (RMD)

Resmed received a Hold rating and a $250.00 price target from J.P. Morgan analyst David Low yesterday. The company’s shares closed last Tuesday at $220.66.

According to TipRanks.com, Low is a 3-star analyst with an average return of 1.8% and a 58.6% success rate. Low covers the Healthcare sector, focusing on stocks such as Fisher & Paykel Healthcare Corporation Limited, Nanosonics Limited, and Cochlear Limited.

Currently, the analyst consensus on Resmed is a Moderate Buy with an average price target of $215.95.

MiMedx Group (MDXG)

H.C. Wainwright analyst Swayampakula Ramakanth maintained a Buy rating on MiMedx Group today and set a price target of $8.00. The company’s shares closed last Tuesday at $3.42, close to its 52-week low of $3.04.

According to TipRanks.com, Ramakanth has 0 stars on 0-5 stars ranking scale with an average return of -8.6% and a 31.2% success rate. Ramakanth covers the Healthcare sector, focusing on stocks such as Diffusion Pharmaceuticals, Janux Therapeutics Inc, and Corcept Therapeutics.

The word on The Street in general, suggests a Moderate Buy analyst consensus rating for MiMedx Group with a $8.50 average price target.

TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.

Read More on NKTR:

• Analysts Offer Insights on Technology Companies: Itron (ITRI), Plexus (PLXS) and BAE Systems (OtherBAESF)
• Analysts Conflicted on These Consumer Goods Names: Church & Dwight (CHD), Dillard’s (DDS) and Carvana Co (CVNA)
• Analysts Offer Insights on Services Companies: Paramount Global Class B (PARA), Tabcorp Holdings Limited (OtherTABCF) and Trainline (OtherTNLIF)
• Wall Street Analysts Are Bullish on Top Utilities Picks
• Analysts’ Opinions Are Mixed on These Financial Stocks: AGNC Investment (AGNC), Ventas (VTR) and Bendigo & Adelaide Bank Ltd. (OtherBXRBF)